While numerous growth stocks continue to struggle, one company operating in the often-neglected care sector is staging a remarkable recovery. Addus HomeCare, a provider of in-home care services, has delivered quarterly results that not only beat expectations but also took market analysts by surprise. The central question for investors is whether this performance indicates durable, long-term growth or merely a short-term rebound.
Robust Earnings and Revenue Drive Momentum
Addus HomeCare’s operational strength was on full display in its second-quarter 2025 report. The company posted adjusted earnings per share of $1.49, a solid beat over the consensus estimate of $1.45. The revenue performance was even more striking, climbing 21.8% year-over-year to reach $349.44 million and surpassing forecasts. These results highlight the firm’s ability to execute effectively within a competitive and challenging market.
Wall Street Responds with Revised Targets
The strong financial update prompted an immediate reaction from the analyst community. Despite maintaining a cautious “Underweight” recommendation, Barclays significantly raised its price target from $83 to $109. Other firms displayed even greater optimism. TD Cowen lifted its target to $139 alongside a “Buy” rating, and JMP Securities issued the most bullish outlook with a $150 price target. The current analyst consensus firmly sits at a “Buy” rating, with an average price target of $142.86.
Should investors sell immediately? Or is it worth buying Addus HomeCare?
Major Investors Signal Strong Confidence
Perhaps the most compelling indicator of Addus HomeCare’s potential is the overwhelming vote of confidence from institutional players. A commanding 95.35% of the company’s outstanding shares are held by institutional investors and hedge funds, signaling deep professional conviction. Recent activity underscores this belief; Invesco Ltd. increased its stake by 19.8% in the first quarter, and Capital Research Global Investors established a new position valued at $51 million. These strategic moves suggest that large-scale investors are reassessing the home care sector and identifying Addus HomeCare as a pivotal investment within it.
The ongoing demographic shift toward an older population and a corresponding rise in the need for care services present a critical long-term opportunity. The market now watches to see if Addus HomeCare can maintain its current momentum and capitalize on these powerful tailwinds.
Ad
Addus HomeCare Stock: Buy or Sell?! New Addus HomeCare Analysis from August 20 delivers the answer:
The latest Addus HomeCare figures speak for themselves: Urgent action needed for Addus HomeCare investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from August 20.
Addus HomeCare: Buy or sell? Read more here...